Comparison of Daratumumab Plus Bortezomib, Melphalan, and Prednisone
(D-VMP) with Standard of Care for Patients from Latin America with Newly
Diagnosed Multiple Myeloma (NDMM) Who Were Transplant Ineligible: A
Propensity Score Matching Analysis
- Publication date
- 1 January 2019
- Publisher